B, N., R, S., NH, R., PH, F., SE, Y., S, C., . . . TH, D. (2024). Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): Sub-cohort report of phase 1 clinical trial. Frontiers in oncology, 14, 1404936. https://doi.org/10.3389/fonc.2024.1404936
Chicago Style (17th ed.) CitationB, Nakamura, et al. "Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Experience in Patients with Recurrent Low Grade Serous Ovarian Carcinoma (LGSOC): Sub-cohort Report of Phase 1 Clinical Trial." Frontiers in Oncology 14 (2024): 1404936. https://doi.org/10.3389/fonc.2024.1404936.
MLA (9th ed.) CitationB, Nakamura, et al. "Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Experience in Patients with Recurrent Low Grade Serous Ovarian Carcinoma (LGSOC): Sub-cohort Report of Phase 1 Clinical Trial." Frontiers in Oncology, vol. 14, 2024, p. 1404936, https://doi.org/10.3389/fonc.2024.1404936.